A $115 billion valuation with no stock exchange involved
Revolut, the London-based financial technology company, completed a secondary share sale valuing the company at $115 billion, according to the Incrypted weekly digest covering November 1–7, 2026. The transaction was led by Glade Brook Capital Partners, Coatue, Durable Capital Partners, T. Rowe Price Associates and Baillie Gifford. No shares were listed on a public exchange. No opening bell rang. Yet the company secured a valuation that would place it among the largest listed financial companies in Europe.
A secondary share sale is a transaction in which existing shareholders — typically employees, early investors or founders — sell their shares to new or existing investors. The company itself issues no new shares and receives no new cash from the sale. The price at which those shares change hands becomes, in effect, the market's verdict on the company's value. For Revolut, that verdict was $115 billion.
The contrast with the traditional path could hardly be sharper. At almost the same moment, Anthropic was reported to be pressing ahead with a pre-Thanksgiving initial public offering, targeting raising $80–100 billion at a $1.25–1.75 trillion valuation, according to investors cited by the Financial Times on November 6–7, 2026. Anthropic's amended S-1 filing on November 2 left the price range blank, and its last confirmed valuation was $965 billion from the May 2026 Series H round. One company is choosing the public markets at an extraordinary scale; the other is achieving a comparable kind of price discovery without them.
Why secondaries have become the default
The rise of the secondary market is best understood as a response to a structural change in how companies are financed. In earlier decades, a fast-growing company needed a public listing to raise large amounts of capital and to give early shareholders a way out. Today, private capital is deep enough that a company can raise billions without ever filing a prospectus. Sovereign wealth funds, crossover funds and large asset managers now compete to buy into the best private companies, and secondary transactions let them do so even when the company itself is not raising money.
For founders and boards, the appeal is control. A public listing brings quarterly earnings pressure, disclosure obligations, short-selling, activist shareholders and a share price that can move on a single headline. A secondary sale delivers many of the benefits of a listing — a credible valuation, liquidity for long-serving employees, a refreshed shareholder register — while the company stays private and its management keeps its freedom of manoeuvre.
For employees, secondaries solve a problem that has grown more acute as companies stay private longer. Equity compensation is only worth something if it can eventually be sold. When a company remains private for a decade or more, employees can find themselves holding valuable paper they cannot spend. Organised secondary sales, often run as tender offers, let them sell a portion of their holdings and realise the reward for years of work.
What founders should weigh
The secondary route is not free of trade-offs. A secondary price is set by negotiation between buyers and sellers in a relatively thin market, not by the continuous auction of a public exchange. That can produce valuations that are harder to defend if conditions change. A company valued at $115 billion in a secondary sale may find that price questioned if it later lists at a lower level, or if a future funding round prices below it.
There is also a question of discipline. Public markets impose a discipline that private markets do not: regular reporting, independent scrutiny and a share price that cannot be ignored. Companies that stay private for a long time can drift away from the standards of financial reporting and governance that a listing demands, and the eventual transition can be painful.
An IPO still makes sense for companies that need very large amounts of primary capital, that want the currency of listed shares for acquisitions, or that benefit from the visibility and credibility a listing confers. Anthropic's reported ambitions illustrate the case: a company raising tens of billions of dollars is operating at a scale where the public markets are the natural venue. For most companies, though, the choice is no longer binary. The modern path is a sequence: private rounds, secondary sales for liquidity, and a listing when — and if — the timing is right.
The takeaway for founders and investors
The lesson of Revolut's $115 billion secondary is that a listing is now a choice rather than a necessity. Founders should treat liquidity as a programme, not an event: plan tender offers for employees, keep the cap table clean, and maintain the reporting standards that would survive public scrutiny even while private. Investors should treat secondary prices as real but provisional — a genuine signal of demand, not the same as a public market price.
Angeled.com connects founders with investors.
The Decoder via FreshSynapse (the-decoder.com via freshsynapse.com)
Read Next
Inovalon to Acquire DrFirst, Uniting Healthcare Data With Prescribing Workflows
Oura to Acquire Counsel Health for $625 Million, Putting a Doctor Behind the Ring
Anthropic Files Updated IPO Prospectus Aiming at a $1.4 Trillion Valuation
Archrock to Acquire HiVolt Energy for Up to $450 Million
Barrick Mining Files to Spin Off and List Its North American Gold Business
What a $1.4 Trillion Anthropic IPO Would Mean for Founders



